title: Metabolic characteristics of glucose intolerance: the critical role of obesity.
abstract: BACKGROUND
  Obesity enhances insulin secretion and resistance. We investigated its importance in linking insulin metabolism to glucose intolerance.
  
  
  METHODS
  We studied 700 subjects referred by general practitioners for possible metabolic abnormalities. Plasma glucose was measured before (FPG) and after (2h-PG) OGTT, together with insulin. Insulin resistance was estimated by HOMA-IR, insulin sensitivity using ISI(gly) and ISI(Stumvoll) indexes, insulin secretion by first (1stPH est) and second phase (2ndPH est) estimates.
  
  
  RESULTS
  Sixty three subjects had impaired glucose tolerance (IGT), 132 impaired fasting glucose (IFG), 63 a mixed disorder (IFG/IGT). Insulin resistance was present only in IGT and IFG/IGT. IFG sub-jects had inappropriately low insulin secretionexclusively during fasting. In a stepwise logistic regression analysis BMI>or=27, female sex and hy-pertension were associated to an altered 2h-PG during OGTT, while hypertension and age were linked to alterations in FPG. While overweight prevalence (BMI>or=7) was higher in all glucose intolerance groups, obesity (BMI>or=30) was typical of IGT. Overweight and obesity were related to higher insulin concentration, secretion and resistance. Obese normal glucose tolerant subjects were more insulin resistant than lean IFG patients.
  
  
  CONCLUSIONS
  OGTT is essential to correctly establish the metabolic derangement of glucose intolerance. Obesity is significantly connected with the impairment of insulin metabolism even in subjects with normal FPG. Considering that both obesity and insulin resistance are independently associated to an increased cardiovascular risk, all overweight subjects, even with normal FPG, should be referred for OGTT evaluation to define glucose tolerance status in order to enforce adequate preventive actions.
authors.affiliation: 1Internal Medicine, Dipartimento di Medicina Clinica e Sperimentale, Università del Piemonte Orientale A. Avogadro, Novara, Italy.
authors.forename: P P
authors.initials: PP
authors.lastname: Sainaghi
authors.forename: L
authors.initials: L
authors.lastname: Castello
authors.forename: L
authors.initials: L
authors.lastname: Bergamasco
authors.forename: G P
authors.initials: GP
authors.lastname: Carnevale Schianca
authors.forename: E
authors.initials: E
authors.lastname: Bartoli
mesh_terms: D000328:Adult; D015992:Body Mass Index; D003924:Diabetes Mellitus, Type 2 / Q000209:etiology / Q000378:metabolism; D005260:Female; D018149:Glucose Intolerance / Q000150:complications* / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000378:metabolism; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications* / Q000378:metabolism*
chemical_list: D007328:Insulin